S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-09
DOI
10.1038/s41375-019-0397-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies
- (2018) Cong Wang et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes
- (2017) Thomas Cluzeau et al. HAEMATOLOGICA
- Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858
- (2017) E A Eksioglu et al. LEUKEMIA
- The emerging role of immune checkpoint based approaches in AML and MDS
- (2017) Prajwal Boddu et al. LEUKEMIA & LYMPHOMA
- Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes
- (2017) Thomas Cluzeau et al. HAEMATOLOGICA
- The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
- (2016) A. A. Basiorka et al. BLOOD
- Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia
- (2016) Noemi A. Zambetti et al. Cell Stem Cell
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia
- (2016) M Qorraj et al. LEUKEMIA
- PD1 and PDL1 upregulation and survival after decitabine treatment in lower risk MDS
- (2016) Sameem Abedin et al. LEUKEMIA & LYMPHOMA
- Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
- (2016) Rebekka K Schneider et al. NATURE MEDICINE
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- 30 MDS GENETIC DAMAGE IS LINKED TO INFLAMMAGING INDUCED BONE MARROW HYPERGLYCEMIA
- (2015) S. Wei et al. LEUKEMIA RESEARCH
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection
- (2014) Matthew M. Staron et al. IMMUNITY
- Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
- (2013) Garrett W. Rhyasen et al. CANCER CELL
- Induction of myelodysplasia by myeloid-derived suppressor cells
- (2013) Xianghong Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis
- (2012) Marc H. G. P. Raaijmakers INTERNATIONAL JOURNAL OF HEMATOLOGY
- Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
- (2012) Ana Chocarro-Calvo et al. MOLECULAR CELL
- Deregulation of innate immune signaling in myelodysplastic syndromes is associated with deletion of chromosome arm 5q
- (2011) Daniel T. Starczynowski et al. CELL CYCLE
- Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
- (2011) Sigurdur Y. Kristinsson et al. JOURNAL OF CLINICAL ONCOLOGY
- Myelodysplastic syndromes and bone marrow microenvironment
- (2011) Matteo Giovanni Della Porta LEUKEMIA RESEARCH
- Innate Immune Signaling in the Myelodysplastic Syndromes
- (2010) Daniel T. Starczynowski et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
- (2010) Marc H. G. P. Raaijmakers et al. NATURE
- TopHat: discovering splice junctions with RNA-Seq
- (2009) Cole Trapnell et al. BIOINFORMATICS
- A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide
- (2009) S. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Myelodysplastic syndromes
- (2008) S. D. Nimer BLOOD
- Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?
- (2008) Derek L. Stirewalt et al. BRITISH JOURNAL OF HAEMATOLOGY
- Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer
- (2008) Olusola Y. Dokun et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment
- (2008) Tony Navas et al. LEUKEMIA & LYMPHOMA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started